Add like
Add dislike
Add to saved papers

Enhanced azo dye Reactive Red 2 degradation in anaerobic reactors by dosing conductive material of ferroferric oxide.

Effect of dosing ferroferric oxide (Fe3 O4 ) on the anaerobic treatment of azo dye Reactive Red 2 (RR2) was investigated in two anaerobic sequencing batch reactors (ASBRs). System performance, dye degradation pathways, and microbial activities and structure were examined. The addition of Fe3 O4 significantly improved treatment efficiency, with the removal efficiency of RR2 increased by 116%, the maximum methane (CH4 ) yield potential and the peak CH4 production rate improved by 7.7% and 22.3%, and the lag phase shortened by 39.6%, respectively. The activity of the electron transport system was significantly enhanced by dosing Fe3 O4 , with the maximum value increased by 77% and conductivity of the anaerobic sludge increased by 178%. According to the proposed pathway for the degradation of RR2, the degradation products from complete cleavage of the NN bond in RR2 were obtained at the presence of Fe3 O4 , while were absent without Fe3 O4 . At high initial dye concentrations, the dosage of Fe3 O4 alleviated the inhibition to microbes by RR2, and high degradation rate and removal efficiency were maintained. The microbial community structure changed during the long-term acclimation with the dosage of Fe3 O4 . Paludibacter, Trichococcus and Methanosarcina were predominant and their relative abundances increased with the addition of Fe3 O4 .

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app